Evotec stands at the forefront of the biotechnology sector as a dynamic R&D powerhouse. Our mission is to expedite the delivery of transformative therapies through accelerating high-value pipeline co-creation partnerships and comprehensive CRO/CDMO services. We are committed to the highest quality and capital-efficient execution of R&D programs, from the foundational stages of disease understanding to IND, Phase 1, and beyond.

Expertise and Modalities – Our expertise is vast, encompassing a wide range of therapeutic and disease areas, with a particular emphasis on small molecules and biotherapeutics. We pride ourselves on our ability to navigate the complexities of drug discovery and development, ensuring that our partners benefit from our extensive knowledge and experience.

Innovative R&D Platforms – At the core of our operations are our industrialized, AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies. These platforms are instrumental in enhancing disease understanding and ensuring human relevance in our research. By integrating AI and continuous manufacturing technology, we facilitate better access to high-quality biotherapeutics, revolutionizing the way treatments are developed and produced.

Global Presence and Flexibility – Evotec’s global footprint is expansive, with a presence that spans continents and a readiness to serve clients wherever they may be. Our state-of-the-art R&D value chain is complemented by highly flexible partnering business models, which are designed to adapt to the unique needs of each project. This approach enables us to deliver medicines that matter with industry-leading efficiency and cost-effectiveness.

In an era where innovation is key to addressing the world’s most pressing health challenges, Evotec emerges as a leader in biotech R&D. Our dedication to quality, efficiency, and global reach positions us as the partner of choice for organizations seeking to accelerate their journey from concept to cure. Through flexible access to our state-of-the-art CRO/CDMO services across the R&D continuum and more than 4,000 scientific experts spanning all disciplines and disease areas, we are working to deliver success for our partners in the most efficient and cost-effective manner. To create medicines that truly matter. Together.